COWEALTH MEDICAL HOLDING CO., LTD. Cowealth Medical Holding Co., Ltd. Stock
Equities
4745
KYG248111042
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.55 TWD | +0.21% |
|
-1.26% | -8.72% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 5.63B 175M 238M | Sales 2023 | 4.81B 150M 204M | Capitalization | 2B 62.23M 84.61M |
|---|---|---|---|---|---|
| Net income 2022 | 94M 2.93M 3.98M | Net income 2023 | 55M 1.71M 2.33M | EV / Sales 2022 | 0.21 x |
| Net cash position 2022 | 735M 22.88M 31.11M | Net cash position 2023 | 280M 8.72M 11.86M | EV / Sales 2023 | 0.36 x |
| P/E ratio 2022 |
20.5
x | P/E ratio 2023 |
35.9
x | Employees | - |
| Yield 2022 |
6.44% | Yield 2023 |
1.55% | Free-Float | 54.48% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.21% | ||
| 1 week | -1.26% | ||
| Current month | +0.21% | ||
| 1 month | -0.21% | ||
| 3 months | -5.23% | ||
| 6 months | -3.88% | ||
| Current year | -8.72% |
1 week
23.40
23.90
1 month
23.0024.00
Current year
23.0025.80
1 year
23.0029.80
3 years
23.0039.00
5 years
21.6244.57
10 years
21.62102.22
| Managers | Title | Age | Since |
|---|---|---|---|
Duane Lee
CEO | Chief Executive Officer | 68 | 06-12-26 |
Chen Chang
DFI | Director of Finance/CFO | - | 10-11-08 |
Qiong Zhi Wang
CHM | Chairman | 67 | 06-12-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chuan Chin
BRD | Director/Board Member | - | 06-12-26 |
Kuang Tsan Tsao
BRD | Director/Board Member | - | - |
Qiong Zhi Wang
CHM | Chairman | 67 | 06-12-26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 23.55 | +0.21% | 81,249 |
| 24-05-15 | 23.5 | -0.21% | 57,099 |
| 24-05-14 | 23.55 | -0.63% | 80,085 |
| 24-05-13 | 23.7 | -0.42% | 18,040 |
| 24-05-10 | 23.8 | +0.42% | 34,175 |
End-of-day quote Taipei Exchange, May 15, 2024
More quotes
Cowealth Medical Holding Co., Ltd. is a Cayman Islands-based holding company primarily engaged in the manufacture and distribution of medical devices and products. The Company's products include cancer treatment and medical testing equipment and reagents and supplies for clinical testing applications. The Company mainly distributes its products in China.
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.72% | 56.63M | |
| +12.50% | 229B | |
| +14.52% | 195B | |
| +17.51% | 142B | |
| +28.96% | 109B | |
| +3.27% | 64.85B | |
| +18.16% | 54.33B | |
| +7.63% | 52.09B | |
| +10.95% | 45.15B | |
| +5.10% | 37.39B |
- Stock Market
- Equities
- 4745 Stock
